Veracyte | VCYT - Pre Tax Profit

Stock Price
41.71
Daily Change
0.21 0.51%
Monthly
24.69%
Yearly
44.78%
Q2 Forecast
37.71

Veracyte reported $29.97M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Agenus USD -10.61M 263.52M Dec/2025
Agilent USD 442M 1000K Sep/2025
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Bruker USD 68.2M 140.8M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Illumina USD 157M 220M Mar/2026
Intrexon USD -60.48M 27.09M Jun/2024
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Laboratory Of America USD 8.73B 8.54B Mar/2026
Ligand Pharmaceuticals USD 56.78M 84.36M Dec/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Siemens EUR 2.94B 559M Dec/2025
Sonic Healthcare AUD 402.01M 53.16M Jun/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Veracyte USD 29.97M 10.66M Mar/2026
Waters USD 264.18M 94.06M Dec/2025